CD 47 is an adverse prognostic factor and a therapeutic target in gastric cancer-Reference-Cited by-同舟云学术

CD 47 is an adverse prognostic factor and a therapeutic target in gastric cancer

Published:2015-06-16 Issue:9 Volume:4 Page:1322-1333
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Yoshida Kazumichi¹,Tsujimoto Hironori¹,Matsumura Kouji²,Kinoshita Manabu³,Takahata Risa¹,Matsumoto Yusuke¹,Hiraki Shuichi¹,Ono Satoshi⁴,Seki Shuhji³,Yamamoto Junji¹,Hase Kazuo¹

Affiliation:

1. Department of Surgery National Defense Medical College Tokorozawa Saitama Japan

2. Laboratory Center National Defense Medical College Tokorozawa Saitama Japan

3. Department of Immunology and microbiology National Defense Medical College Tokorozawa Saitama Japan

4. Division of Traumatology National Defense Medical College Tokorozawa Saitama Japan

Funder

JSPS KAKENHI

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.478

Reference41 articles.

1. Roles of inflammatory cytokines in the progression of gastric cancer: friends or foes?

2. International variation

3. Stem cells, cancer, and cancer stem cells

4. Stem Cells and Cancer: Two Faces of Eve

5. Expression of cancer stem cell markers ALDH1, CD44 and CD133 in primary tumor and lymph node metastasis of gastric cancer

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polypeptides-Based Nanocarriers in Tumor Therapy;Pharmaceutics;2024-09-10

2. Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment;Journal of Pharmaceutical Analysis;2024-09

3. A pan-allelic human SIRPα-blocking antibody, ES004-B5, promotes tumor killing by enhancing macrophage phagocytosis and subsequently inducing an effective T-cell response;Antibody Therapeutics;2024-07

4. Clinicopathological analysis of immunohistochemical CD47 and signal-regulatory protein-α expression in Extranodal Natural killer/T-cell lymphoma;Annals of Hematology;2024-06-18

5. Advances in targeted therapy for human epidermal growth factor receptor 2 positive in advanced gastric cancer;World Journal of Gastrointestinal Oncology;2024-06-15